Tilray Brands, Inc. (TLRY)'s Potential Upside Meets a Cautious Consensus

Tilray Brands, Inc. (NASDAQ:TLRY) is among the Best Get Rich Fast Stocks to Buy Right Now. As of December 24, Tilray Brands, Inc. (NASDAQ:TLRY) has mixed analyst sentiment, with slightly more than 60% of analysts covering the stock assigning a Hold rating and the remaining 36% recommending buying the stock. While the target price ranges from $8.50 to $25, the median price target of $19 reflects an upside potential of 88.49%.

On December 22, Nadine Sarwat, an analyst at Bernstein, reiterated a ‘Market Perform’ rating on Tilray Brands, Inc. (NASDAQ:TLRY), while substantially raising the price target to $10 from $1.

The firm highlighted President Trump’s cannabis- related Executive Order that has two aims: directing the Attorney General to take all the necessary steps to reschedule cannabis from Schedule I to III, and instructing his Administration to work with Congress to revise the statutory definition of hemp-derived cannabinoid product to incorporate many full-spectrum CBD products. This would also involve establishing a regulatory approach for these offerings and accelerating research.

Bernstein pointed out that cannabis has largely emerged as a bipartisan issue, with Gallup revealing that 64% of Americans are in favour of cannabis legalization in 2025. Despite it being a meaningful figure, it still represents a drop from the 70% peak reported in 2023.

Tilray Brands, Inc. (NASDAQ:TLRY) is a Canadian lifestyle consumer products company specializing in medical cannabis products. Incepted in 2018, the company operates through four segments: Beverage, Cannabis, Distribution, and Wellness.

While we acknowledge the potential of TLRY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None.